Larvol Delta - Allogenic-CD123CARNK-Cells-in-the-Treatment-of-RefractoryRelapsed-Acute-Myeloid-Leukemia

JD023 - Beijing JD Biotech

http://clinicaltrials.gov/ct2/show/NCT05574608

Oct 11, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev